<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37395001</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Systemic lupus erythematosus-related acute lung disease.</ArticleTitle><Pagination><StartPage>1117</StartPage><EndPage>1122</EndPage><MedlinePgn>1117-1122</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231188034</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Systemic lupus erythematosus (SLE) is non-organ specific autoimmune disease with mainly skin, joint, and kidney involvement. SLE-related acute lung disease (ALD) is rare, poorly investigated and can lead to acute respiratory failure. We conducted a retrospective study aiming to describe clinical features, treatments and outcome of SLE-related APD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively included all patients with SLE and ALD admitted from November 1996 and September 2018 to La Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital, after exclusion of viral or bacterial lung infection, cardiac failure or any other alternate diagnosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the time of the study, 14 patients with 16 episodes were admitted to our center: female 79%, mean age &#xb1; SD at admission 24 &#xb1; 11&#xa0;years. ALD was inaugural of the SLE in 70% cases. SLE main organ involvement were: arthritis 93%, skin 79%, serositis 79%, hematological 79%, kidney 64%, neuropsychiatric 36% and cardiac 21%. 11 episodes required ICU admission for a median time of 8&#xa0;days. Chest CT-scan revealed mostly basal consolidation and ground-glass opacities. When available, bronchoalveolar lavage mostly revealed a neutrophilic alveolitis with alveolar hemorrhage in 67% cases. Symptomatic respiratory treatments were: oxygen 81%, high-flow nasal canula oxygen 27%, non-invasive ventilation 36%, mechanical ventilation 64% and venovenous extracorporeal membrane oxygenation 18%. SLE-specific treatments were: corticosteroids 100%, cyclophosphamide 56% and plasma exchange 25%. All patients but one survived to ICU and hospital discharge. Two patients had a relapse of SLE-related ALD but none had interstitial lung disease during follow-up.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Systemic lupus erythematosus-related acute respiratory failure is a severe event, mostly occurring at SLE onset, typical harboring a basal consolidation pattern on chest CT-scan and alveolar hemorrhage on BAL pathological examination. Mortality in our cohort is lower than previously reported but these results needs to be confirmed in further larger studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Triboulet</LastName><ForeName>F&#xe9;licien</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu&#xe9;rin</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boussouar</LastName><ForeName>Samia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>D&#xe9;partement d'Imagerie Cardiothoracique, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe9;kimian</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pha</LastName><ForeName>Micheline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouvier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service d'Anatomopathologie, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathian</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quentric</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Inserm, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moyon</LastName><ForeName>Quentin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hi&#xe9;</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>UMRS_1166-ICAN, Inserm, Institut de Cardiom&#xe9;tabolisme et Nutrition (ICAN), Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combes</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>UMRS_1166-ICAN, Inserm, Institut de Cardiom&#xe9;tabolisme et Nutrition (ICAN), Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luyt</LastName><ForeName>Charles-Edouard</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>UMRS_1166-ICAN, Inserm, Institut de Cardiom&#xe9;tabolisme et Nutrition (ICAN), Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoura</LastName><ForeName>Zahir</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Inserm, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pineton de Chambrun</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6321-858X</Identifier><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne 2, Centre de R&#xe9;f&#xe9;rence National Lupus Syst&#xe9;mique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Immunes Syst&#xe9;miques Rares, Institut E3M, Assistance Publique-H&#xf4;pitaux de Paris (APHP), H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, APHP, H&#xf4;pital La Piti&#xe9;-Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Inserm, Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>UMRS_1166-ICAN, Inserm, Institut de Cardiom&#xe9;tabolisme et Nutrition (ICAN), Sorbonne Universit&#xe9;, Paris, France.</Affiliation><Identifier Source="RINGGOLD">27063</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="Y">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">alveolar hemorrhage</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">lupus pneumonitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37395001</ArticleId><ArticleId IdType="doi">10.1177/09612033231188034</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>